Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Journal of Cancer ; (12): 153-162, 2011.
Artículo en Inglés | WPRIM | ID: wpr-296301

RESUMEN

The increasing incidence and mortality associated with advanced stages of melanoma are cause for concern. Few treatment options are available for advanced melanoma and the 5-year survival rate is less than 15%. Targeted therapies may revolutionize melanoma treatment by providing less toxic and more effective strategies. However, maximizing effectiveness requires further understanding of the molecular alterations that drive tumor formation, progression, and maintenance, as well as elucidating the mechanisms of resistance. Several different genetic alterations identified in human melanoma have been recapitulated in mice. This review outlines recent progress made in the development of mouse models of melanoma and summarizes what these findings reveal about the human disease. We begin with a discussion of traditional models and conclude with the recently developed RCAS/TVA somatic cell gene delivery mouse model of melanoma.


Asunto(s)
Animales , Humanos , Ratones , 9,10-Dimetil-1,2-benzantraceno , Virus de la Leucosis Aviar , Genética , Proteínas Aviares , Genética , Metabolismo , Línea Celular Tumoral , Modelos Animales de Enfermedad , Técnicas de Transferencia de Gen , Vectores Genéticos , Genética , Melanocitos , Metabolismo , Melanoma , Genética , Patología , Melanoma Experimental , Genética , Ratones Transgénicos , Trasplante de Neoplasias , Receptores Virales , Genética , Metabolismo , Neoplasias Cutáneas , Genética , Patología , Acetato de Tetradecanoilforbol , Transgenes
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA